Midmark honored as a Healthiest Employer in Ohio and Michigan
Midmark Corp., has been recognized as one of the Healthiest Employers of Ohio and Michigan. The awards program, powered by Springbuk, was created to honor people-first organizations that prioritize the well-being of their employee population. These companies were recognized because of their commitment to workplace wellness and their exceptional health and benefits offerings. Award applicants were evaluated across six key categories: Culture and Leadership, Foundational Components, Strategic Planning, Communication and Marketing, Programming and Interventions, and Reporting and Analytics. Completed assessments were ranked with the proprietary Healthiest Employers Index, a 1-100 rubric for wellness programming.
“Wellness has not only become very educational for our teammates, but they also enjoy group participation, challenges and contests hosted by our ‘FIT’ team,” said Sue Hulsmeyer, vice president, human resources and corporate communications. “We are currently building and remodeling our Versailles campus, and our teammates are looking forward to a new fitness center and outdoor track that will be part of our facilities.”
BD to invest $1.2B in pre-fillable syringe manufacturing capacity over next 4 years
BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations and add a new manufacturing facility in Europe.
The new manufacturing facility in Europe is expected to be operational by the end of 2023.
BD says that the investment will also fund capacity expansion, new product innovations, manufacturing technology enhancements and business continuity improvements across its existing network. All of the investments are designed to maximize supply and reduce risks for pharmaceutical companies that rely on ready-to-fill syringes for their injectable drugs – including complex biologics, vaccines and small molecules.
The six current manufacturing facilities for BD Pharmaceutical Systems that will see a portion of this investment include facilities in:
- Columbus, Nebraska
- Cuautitlán, Mexico
- Fukushima, Japan
- Le Pont-de-Claix, France
- Swindon, United Kingdom
- Tatabánya, Hungary
“Since 2018, BD has added 350 million units of manufacturing capacity for glass barrel pre-fillable syringes, and this new commitment will invest in additional upgrades at all of our Pharmaceutical Systems manufacturing facilities and across multiple product categories,” said Eric Borin, worldwide president of BD Pharmaceutical Systems. “In addition, this investment positions BD to have the needed surge capacity for increased pre-fillable syringe demand during times of pandemic response or periods of significant growth of new injectable drugs and vaccines.”
Dale Medical Products implements new sales strategy
Dale Medical Products, Inc., announced it has selected MedTech MedCare (MTMC) to lead Dale’s sales efforts within the United States, effective Jan. 1, 2021. Jack Moran, Managing Partner at MTMC stated “MTMC has developed an effective, efficient team of sales professionals representing leading brands nationwide. Dale’s product portfolio is well aligned with MTMC’s core competencies and we will be able to leverage their brand recognition in generating further market expansion for Dale.”
John Brezack, Dale’s President, commented: “Dale has been growing steadily for the entire history of the company. We have made the decision to focus on expanding our reach, and ultimately provide our products on a larger scale in order to support clinicians and improve patient outcomes and satisfaction.”